Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'combination therapy' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1756 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pomerantz, RJ
      Reservoirs of human immunodeficiency virus type 1: The main obstacles to viral eradication

      CLINICAL INFECTIOUS DISEASES
    2. Freund, YR; Dousman, L; Riccio, ES; Sato, B; MacGregor, JT; Mohagheghpour, N
      Immunohematotoxicity studies with combinations of dapsone and zidovudine

      INTERNATIONAL IMMUNOPHARMACOLOGY
    3. Gately, S; Kerbel, R
      Antiangiogenic scheduling of lower dose cancer chemotherapy

      CANCER JOURNAL
    4. Kyriakides, TC; Heimer, RR
      Development and application of a genotypic AZT resistance assay - Quantitative assessment of the resistance profile of clinical samples and the relative predictive ability of a resistance index

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Stuart, JWTC; Wensing, AMJ; Kovacs, C; Righart, M; de Jong, D; Kaye, S; Schuurman, R; Visser, CJT; Boucher, CAB
      Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Manfredi, R
      A cross-sectional survey of HIV genotype mutations conferring resistance to all nonnucleoside reverse transcriptase inhibitors and related features, at the time of failure of antiretroviral therapy in the real world

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    7. Nunez, M; Lana, R; Mendoza, JL; Martin-Carbonero, L; Soriano, V
      Risk factors for severe hepatic injury after introduction of highly activeantiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    8. Miller, MD; Margot, NA; Lamy, PD; Fuller, MD; Anton, KE; Mulato, AS; Cherrington, JM
      Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: Genotypic and phenotypic analyses of study GS-96-408

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    9. Ruiz, L; Negredo, E; Domingo, P; Paredes, R; Francia, E; Balague, M; Gel, S; Bonjoch, A; Fumaz, CR; Johnston, S; Romeu, J; Lange, J; Clotet, B
      Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    10. Funk, GA; Fischer, M; Joos, B; Opravil, M; Gunthard, HF; Ledergerber, B; Bonhoeffer, S
      Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    11. Rousseau, MN; Vergne, L; Montes, B; Peeters, M; Reynes, J; Delaporte, E; Segondy, M
      Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-Infected patients with failure of highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Loveday, C
      Nucleoside reverse transcriptase inhibitor resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    13. Zisman, A; Ng, CP; Pantuck, AJ; Bonavida, B; Belldegrun, AS
      Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis

      JOURNAL OF IMMUNOTHERAPY
    14. Klareskog, L; Nordmark, B; Lindblad, S
      On the organization of an early arthritis clinic

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    15. O'Dell, JR
      How is it best to treat early rheumatoid arthritis patients?

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    16. Pincus, T; Sokka, T
      How can the risk of long-term consequences of rheumatoid arthritis be reduced?

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    17. March, L; Lapsley, H
      What are the costs to society and the potential benefits from the effective management of early rheumatoid arthritis?

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    18. Ullenhag, G; Bird, C; Ragnhammar, P; Frodin, JE; Strigard, K; Osterborg, A; Thorpe, R; Mellstedt, H; Wadhwa, M
      Incidence of GM-CSF antibodies in cancer patients receiving GM-CSF for immunostimulation

      CLINICAL IMMUNOLOGY
    19. Marzilli, M
      Trimetazidine: a metabolic agent for the treatment of stable angina

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    20. Memish, ZA; Venkatesh, S
      Brucellar epididymo-orchitis in Saudi Arabia: a retrospective study of 26 cases and review of the literature

      BJU INTERNATIONAL
    21. Quinn, MA; Conaghan, PG; Emery, P
      The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence?

      RHEUMATOLOGY
    22. Sasadeusz, J
      Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones

      INTERNAL MEDICINE JOURNAL
    23. Rossi, M; Flepp, M; Telenti, A; Schiffer, V; Egloff, N; Bucher, H; Vernazza, P; Bernasconi, E; Weber, R; Rickenbach, M; Furrer, H
      Disseminated M-avium complex infection in the Swiss HIV cohort study: Declining incidence, improved prognosis and discontinuation of maintenance therapy

      SWISS MEDICAL WEEKLY
    24. Flepp, M; Schiffer, V; Weber, R; Hirschel, B
      Modern anti-HIV therapy

      SWISS MEDICAL WEEKLY
    25. van de Kerkhof, PCM
      New developments in the treatment of psoriasis

      SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY
    26. Garcia-Lerma, JG; Heneine, W
      Resistance of human immunodeficiency virus type 1 to reverse transcriptaseand protease inhibitors: genotypic and phenotypic testing

      JOURNAL OF CLINICAL VIROLOGY
    27. Koch, N; Tamalet, C; Tivoli, N; Fantini, J; Yahi, N
      Comparison of two commercial assays for the detection of insertion mutations of HIV-1 reverse transcriptase

      JOURNAL OF CLINICAL VIROLOGY
    28. Grahovac, B; Bingulac-Popovic, J; Vucelic, B; Hrstic, I; Ostojic, R; Drazic, V; Balija, M; Grgicevic, D
      Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C

      JOURNAL OF CLINICAL VIROLOGY
    29. Hwang, SJ; Lee, SD; Chu, CW; Lu, RH; Chang, FY
      An open-label trial of consensus interferon 15 mu g in the treatment of Chinese patients with chronic hepatitis C

      HEPATOLOGY RESEARCH
    30. Chodak, GW; Kolvenbag, GJCM
      Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer?

      PROSTATE CANCER AND PROSTATIC DISEASES
    31. Buss, N; Cammack, N
      Measuring the effectiveness of antiretroviral agents

      ANTIVIRAL THERAPY
    32. Vandamme, AM; Houyez, F; Banhegyi, D; Clotet, B; De Schrijver, G; De Smet, KAL; Hall, WW; Harrigan, R; Hellmann, N; Hertogs, K; Holtzer, C; Larder, B; Pillay, D; Race, E; Schmit, JC; Schuurman, R; Shulse, E; Sonnerborg, A; Miller, V
      Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up

      ANTIVIRAL THERAPY
    33. Saracino, A; Di Stefano, M; Vimercati, A; Greco, P; Fiore, JR; Monno, L; Angarano, G; Pastore, G
      Cervicovaginal HIV-1 shedding in pregnant women near delivery

      ANTIVIRAL THERAPY
    34. Pillay, D
      The emergence and epidemiology of resistance in the nucleoside-experiencedHIV-infected population

      ANTIVIRAL THERAPY
    35. Miller, V; Larder, BA
      Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure

      ANTIVIRAL THERAPY
    36. Lange, J
      A rational approach to the selection and sequencing of nucleoside/nucleotide analogues: a new paradigm

      ANTIVIRAL THERAPY
    37. Wainberg, MA; White, AJ
      Current insights into reverse transcriptase inhibitor-associated resistance

      ANTIVIRAL THERAPY
    38. Hoetelmans, R
      Pharmacological exposure and the development of drug resistance in HIV

      ANTIVIRAL THERAPY
    39. White, WB
      Controlling blood pressure with combination therapy: the role of angiotensin II receptor blockers combined with diuretics

      BLOOD PRESSURE MONITORING
    40. McGill, JB
      Angiotensin II receptor antagonist plus a thiazide diuretic is more efficacious for treating hypertension than either drug alone

      BLOOD PRESSURE MONITORING
    41. Littlejohn, TW
      Clinical considerations in hypertensive black patients: the role of angiotensin II receptor blockers in combination with a diuretic

      BLOOD PRESSURE MONITORING
    42. Lacourciere, Y
      Usefulness of combination therapy in hypertensive patients who do not respond to an angiotensin type 1 receptor antagonist alone

      BLOOD PRESSURE MONITORING
    43. Scully, C; Dios, PD
      Orofacial effects of antiretroviral therapies

      ORAL DISEASES
    44. Dao, HH; Moreau, P
      An update on the status of endothelin receptor antagonists for hypertension

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    45. Andreone, P; Cursaro, C; Gramenzi, A; Margotti, M; Ferri, E; Talarico, S; Biselli, M; Felline, F; Tuthill, C; Martins, E; Gasbarrini, G; Bernardi, M
      In vitro effect of thymosin-alpha 1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C

      JOURNAL OF VIRAL HEPATITIS
    46. Papoz, L
      Insulin treatment in type 2 diabetic patients : epidemiological data

      DIABETES & METABOLISM
    47. Plosker, GL; Perry, CM; Goa, KL
      Efavirenz - A pharmacoeconomic review of its use in HIV infection

      PHARMACOECONOMICS
    48. Diago, M; Lujan, M; Valeros, D; Tuset, C; Marcaida, G; Garcia, V; Cors, R; Carbonell, P
      Long-term response to interferon plus ribavirin in patients with chronic hepatitis C refractory to interferon

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    49. Baughman, RP; Ohmichi, M; Lower, EE
      Combination therapy for sarcoidosis

      SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES
    50. Garbuglia, AR; Zaccarelli, M; Calcaterra, S; Cappiello, G; Marini, R; Benedetto, A
      Dynamics of viral load in plasma and HIV DNA in lymphocytes during highly active antiretroviral therapy (HAART): High viral burden in macrophages after 1 year of treatment

      JOURNAL OF CHEMOTHERAPY
    51. Edelstein, MA; Martin, P
      Chronic hepatitis C: Current status and rationale for antiviral therapy

      EUROPEAN JOURNAL OF SURGERY
    52. Akhter, MP; Kimmel, DB; Recker, RR
      Effect of parathyroid hormone (hPTH[1-84]) treatment on bone mass and strength in ovariectomized rats

      JOURNAL OF CLINICAL DENSITOMETRY
    53. Ross, L; Henry, K; Paar, D; Salvato, P; Shaefer, M; Fisher, R; Liao, QM; St Clair, M
      Thymidine-analog and multi-nucleoside resistance mutations are observed inboth zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens

      JOURNAL OF HUMAN VIROLOGY
    54. Yazdani, C; McLaughlin, T; Cummins, G; Doyle, J
      Comparison of rheumatoid arthritis care costs in patients starting therapywith leflunomide versus etanercept

      AMERICAN JOURNAL OF MANAGED CARE
    55. Marciante, KD; Ramsey, SD
      Short-term costs versus long-term gains: The trade-off for glitazone therapy

      AMERICAN JOURNAL OF MANAGED CARE
    56. Brook, MG; Dale, A; Tomlinson, D; Waterworth, C; Daniels, D; Forster, G
      Adherence to highly active antiretroviral therapy in the real world: experience of twelve English HIV units

      AIDS PATIENT CARE AND STDS
    57. Sonza, S; Crowe, SM
      Reservoirs for HIV infection and their persistence in the face of undetectable viral load

      AIDS PATIENT CARE AND STDS
    58. Hatzakis, A; Gargalianos, P; Kiosses, V; Lazanas, M; Sypsa, V; Anastassopoulou, C; Vigklis, V; Sambatakou, H; Botsi, C; Paraskevis, D; Stalgis, C
      Low-dose IFN-alpha monotherapy in treatment-naive individuals with HIV-1 infection: Evidence of potent suppression of viral replication

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    59. Godley, P; Pham, H; Rohack, J; Woodward, B; Yokoyama, K; Maue, SK
      Opportunities for improving the quality of hypertension care in a managed care setting

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    60. Ancell, CD; Phipps, J; Young, L
      Thymosin alpha-1

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    61. Nelson, KE; Thomas, DL
      Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infections

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    62. Bruno-Joyce, J; Dugas, JM; MacCausland, OE
      Cerivastatin and gemfibrozil-associated rhabdomyolysis

      ANNALS OF PHARMACOTHERAPY
    63. Omar, MA; Wilson, JP; Cox, TS
      Rhabdomyolysis and HMG-CoA reductase inhibitors

      ANNALS OF PHARMACOTHERAPY
    64. Segarra-Newnham, M; Vodolo, KM
      Use of cidofovir in progressive multifocal leukoencephalopathy

      ANNALS OF PHARMACOTHERAPY
    65. Graham, CS; Baden, LR; Yu, E; Mrus, JM; Carnie, J; Heeren, T; Koziel, MJ
      Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis

      CLINICAL INFECTIOUS DISEASES
    66. Murphy, EL; Assmann, SF; Collier, AC; Flanigan, TP; Kumar, PN; Wallach, FR; Krubel, S
      Determinants of antimicrobial prophylaxis use and treatment for wasting among patients with advanced human immunodeficiency virus disease in the United States, 1995-1998

      CLINICAL INFECTIOUS DISEASES
    67. Papadakis, JA; Milionis, HJ; Press, M; Mikhailidis, DP
      Treating dyslipidaemia in non-insulin-dependent diabetes mellitus - a special reference to statins

      JOURNAL OF DIABETES AND ITS COMPLICATIONS
    68. Taylor, DO; Barr, ML; Meiser, BM; Pham, SM; Mentzer, RM; Gass, AL
      Suggested guidelines for the use of tacrolimus in cardiac transplant recipients

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    69. Marcus, A
      Current lipid-lowering strategies for the treatment of diabetic dyslipidemia: An integrated approach to therapy

      ENDOCRINOLOGIST
    70. Chen, BJ
      Triptolide, a novel immunosuppressive and anti-inflammatory agent purifiedfrom a Chinese herb Tripterygium Wilfordii Hook F

      LEUKEMIA & LYMPHOMA
    71. Chisesi, T; Polistena, P; Contu, A; Coser, P; Indrizzi, L; Leoni, P; Majolino, I; Porcellini, A; Salvagno, L; Zambaldi, G; Rizzoli, V; Congiu, AM; Santini, G
      Cemp, a mitoxantrone containing combination, in the treatment of intermediate and high grade non-Hodgkin's lymphoma: An effective and non toxic therapeutic alternative for adult and elderly patients

      LEUKEMIA & LYMPHOMA
    72. Fang, SH; Lai, MY; Hwang, LH; Yang, PM; Chen, PJ; Chiang, BL; Chen, DS
      Ribavirin enhances interferon-gamma levels in patients with chronic hepatitis C treated with interferon-alpha

      JOURNAL OF BIOMEDICAL SCIENCE
    73. Chen, JW; Madamanchi, N; Madamanchi, NR; Trier, TT; Keherly, MJ
      Lamp-1 is upregulated in human glioblastoma cell lines induced to undergo apoptosis

      JOURNAL OF BIOMEDICAL SCIENCE
    74. Agrawal, S; Kandimalla, ER; Yu, D; Hollister, BA; Chen, SF; Dexter, DL; Alford, TL; Hill, B; Bailey, KS; Bono, CP; Knoerzer, DL; Morton, PA
      Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides

      INTERNATIONAL JOURNAL OF ONCOLOGY
    75. van Rossum, MM; van Erp, PEJ; van de Kerkhof, PCM
      Treatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: A flow cytometric study

      DERMATOLOGY
    76. Grotta, J
      Combination therapy stroke trial: Recombinant tissue-type plasminogen activator with/without lubeluzole

      CEREBROVASCULAR DISEASES
    77. Kaste, M
      Thrombolysis in ischaemic stroke - Present and future: Role of combined therapy

      CEREBROVASCULAR DISEASES
    78. Raab, GM; Parpia, T
      Random effects models for HIV marker data: practical approaches with currently available software

      STATISTICAL METHODS IN MEDICAL RESEARCH
    79. Takada, K; Illei, GG; Boumpas, DT
      Cyclophosphamide for the treatment of systemic lupus erythematosus

      LUPUS
    80. Griffiths, B; Emery, P
      The treatment of lupus with cyclosporin A

      LUPUS
    81. Tirelli, U; Bernardi, D
      Impact of HAART on the clinical management of AIDS-related cancers

      EUROPEAN JOURNAL OF CANCER
    82. Lieberman, A; Minagar, A; Pinter, MM
      The efficacy of pramipexole in the treatment of Parkinson's disease

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    83. Jackson, G
      Haemodynamic and metabolic agents in the treatment of stable angina: publication review

      CORONARY ARTERY DISEASE
    84. van Rensburg, CJ; Bardhan, KD
      No clinical benefit of adding cisapride to pantoprazole for treatment of gastro-oesophageal reflux disease

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    85. Ferenci, P; Stauber, R; Steindl-Munda, P; Gschwantler, M; Fickert, P; Datz, C; Muller, C; Hackl, F; Rainer, W; Watkins-Riedel, T; Lin, W; Krejs, GJ; Gangl, A
      Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    86. Nguyen, MH; Wright, TL
      Therapeutic advances in the management of hepatitis B and hepatitis C

      CURRENT OPINION IN INFECTIOUS DISEASES
    87. Sharkey, ME; Stevenson, M
      Two long terminal repeat circles and persistent HIV-1 replication

      CURRENT OPINION IN INFECTIOUS DISEASES
    88. Stellbrink, HJ; van Lunzen, J
      Lymph nodes during antiretroviral therapy

      CURRENT OPINION IN INFECTIOUS DISEASES
    89. Nijhuis, M; Deeks, S; Boucher, C
      Implications of antiretroviral resistance on viral fitness

      CURRENT OPINION IN INFECTIOUS DISEASES
    90. Hilleman, DE; Reyes, AP; Wurdeman, RL; Faulkner, M
      Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension

      JOURNAL OF HUMAN HYPERTENSION
    91. Piot, O; Gallois, H; Baguet, JP; Mallion, JM
      First-line treatment of hypertension: from monotherapy to fixed low-dose combination therapy

      JOURNAL OF HUMAN HYPERTENSION
    92. Pool, J; Kaihlanen, P; Lewis, G; Ginsberg, D; Oparil, S; Glazer, R; Messerli, FH
      Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone

      JOURNAL OF HUMAN HYPERTENSION
    93. Lacourciere, Y; Tytus, R; O'Keefe, D; Lenis, J; Orchard, R; Martin, K
      Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy

      JOURNAL OF HUMAN HYPERTENSION
    94. Boger, RH
      Drug interactions of them statins and consequences for drug selection

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    95. Hamouda, T; Myc, A; Donovan, B; Shih, AY; Reuter, JD; Baker, JR
      A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi

      MICROBIOLOGICAL RESEARCH
    96. Tanuma, H; Tanuma, M; Abe, M; Kume, H
      Usefulness of Lanoconazole (Astat (R)) cream in the treatment of hyperkeratotic type tinea pedis. Comparative study of monotherapy and combination therapy with 10% Urea Ointment (Pastaron (R))

      MYCOSES
    97. Kao, JH; Lai, MY; Chen, PJ; Cheng, YM; Chen, DS
      Prolonged interferon treatment after combination interferon and ribavirin therapy in patients with chronic hepatitis C: A clinical trial of interferon relapsers and non-responders

      JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    98. Shimizu, T; Shimada, H; Ochiai, T; Hamada, H
      Enhanced growth suppression in esophageal carcinoma cells using adenovirus-mediated fusion gene transfer (uracil phosphoribosyl transferase and herpes simplex virus thymidine kinase)

      CANCER GENE THERAPY
    99. Rait, AS; Pirollo, KF; Rait, V; Krygier, JE; Xiang, LM; Chang, EH
      Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer

      CANCER GENE THERAPY
    100. Leyland-Jones, B; Arnold, A; Gelmon, K; Verma, S; Ayoub, JP; Seidman, A; Dias, R; Howell, J; Rakhit, A
      Pharmacologic insights into the future of trastuzumab

      ANNALS OF ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/05/20 alle ore 12:50:45